NLS

Aprea AB has announced that dosing has begun in the Phase I/II proof-of-concept clinical trial of APR-246 in combination with chemotherapy in patients with relapsed platinum sensitive high grade serous ovarian cancer. Cancers develop and spread due to the malfunction of the cells’ normal growth control mechanisms. One of the best-known cancer genes is p53 […]

Being prepared for daily changes and remembering to work hard, do your best and listen to others are some of the principles that have guided CellaVision CEO Yvonne Mårtensson throughout her career.

The Swedish drug discovery company has announced that the FDA has granted clearance to proceed with VLX600 into the clinical phase I/II. VLX600 is one of the company’s drug projects, recently published in the journal Nature Communications. The drug candidate kills sleeping cell populations in regions of solid tumors that are metabolically compromised due to poor vascularization – areas that cannot […]

The arrested Getinge employee suspected of insider dealing has now been detained. The man is detained on resasonable grounds suspected for inside dealing, reports Swedish news site realtid.se. Committal proceedings were initiated on April 11. Prosecutor Jan Leopoldson has sent in a remand order where he refers to the risks of the suspect eliminating evidence […]

Researchers at Umeå University and SLU in Umeå will together with AcureOmics AB get a SEK 4 million funding for a transplant research project. The project is focused on developing new methods to early identify risks of rejection of transplanted kidneys. “If we can discover rejection processes in transplanted kidneys at an earlier stage it […]

Moberg Pharma has acquired the global rights to a novel topical formulation for the treatment of oral pain. The company has announced that it has entered into a definitive agreement with Danish Oracain II Aps to acquire all assets as well as global rights to a novel and patent pending oral formulation of the proven […]